Clinical Trials

Randomized study of autologous stem cell transplantation with high-dose melphalan versus high-dose melphalan and bortezomib in patients with MM 60 years or older


Study ID
HUMC Pro 00001307

NCT Number
NCT01453088 (Click on the NCT number for more information about the trial)

Research Study Number
1307

Principle Investigator
Dr. Michele Donato

Phase
III

Sponsor
HackensackUMC


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now